Likely uptake of a future lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study

BMC Pulmonary Medicine

Table 5 Factors associated with lung cancer screening hesitancy (n = 158)

Variable	Univariable			Multivariable
	Odds ratio	Confidence interval	p value	Odds ratio	Confidence interval	p value
Male gender	2.52	1.13–5.61	< 0.05	5.94	1.64–21.44	< 0.01
Age	1.01	0.95–1.05	0.41	0.99	0.92–1.06	0.87
Years since treatment	0.98	0.93–1.03	0.44	0.91	0.83–1.00	0.06
LOT-R score	1.04	0.95–1.14	0.31	1.18	0.97–1.43	0.08
Living in an area with a high IMD decile	1.43	0.61–3.37	0.40	8.22	1.59–42.58	< 0.05
No family history of lung cancer	1.23	0.25–5.96	0.78	0.17	0.01–2.20	0.17
Never smoker	1.21	0.53–2.74	0.64	0.80	0.20–3.17	0.76
Cancer worry severity score	0.84	0.59–1.20	0.35	1.01	0.51–1.98	0.97
Self-rated health score	1.11	0.75–1.63	0.59	0.60	0.27–1.31	0.20
Lower perceived risk	1.17	0.98–1.40	0.08	1.03	0.73–1.45	0.82
Lower perceived benefits	1.29	1.14–1.47	< 0.01	1.23	0.98–1.53	0.06
Higher perceived barriers	1.09	1.03–1.15	< 0.01	1.03	0.95–1.12	0.37
Lower self-efficacy	1.45	1.27–1.65	< 0.01	1.64	1.30–2.08	< 0.01

ISSN: 1471-2466